Atropine Sulfate — 8MG, Injection, carton of 10 × 20 mL vials

Atropine Sulfate — 8MG, Injection, carton of 10 × 20 mL vials

Atropine Sulfate is a injection for endotracheal; intramedullary; intramuscular; intravenous; subcutaneous use. Atropine is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus, carbamate, or muscarinic mushroom poisoning, and to treat symptomatic bradycardia. Atropine is a muscarinic antagonist indicated for temporary blockade of severe or life threatening muscarinic effects. ( 1 )

• Active ingredient or product type: ATROPINE SULFATE
• Strength/concentration: 8MG
• Dosage form and route: Injection, Endotracheal; Intramedullary; Intramuscular; Intravenous; Subcutaneous
• Exact package presentation: carton of 10 × 20 mL vials
• NDC/item number: 0641-6251-10
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at controlled room temperature according to the current product labeling.
• Status: Rx only

Important safety information: Hypersensitivity ( 5.1 ) Worsening of Ischemic Heart Disease ( 5.2 ) Acute Glaucoma ( 5.3 ) Pyloric obstruction ( 5.4 ) Complete urinary retention ( 5.5 ) Viscid plugs ( 5.6 ) 5.1 Hypersensitivity Atropine may cause anaphylaxis.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.